Bacteria possess an extraordinary
repertoire of cell envelope glycans
that have critical physiological functions. Pathogenic bacteria have
glycans that are essential for growth and virulence but are absent
from humans, making them high-priority targets for antibiotic, vaccine,
and diagnostic development. The advent of metabolic labeling with
bioorthogonal chemical reporters and small-molecule fluorescent reporters
has enabled the investigation and targeting of specific bacterial
glycans in their native environments. These tools have opened the
door to imaging glycan dynamics, assaying and inhibiting glycan biosynthesis,
profiling glycoproteins and glycan-binding proteins, and targeting
pathogens with diagnostic and therapeutic payload. These capabilities
have been wielded in diverse commensal and pathogenic Gram-positive,
Gram-negative, and mycobacterial speciesincluding within live
host organisms. Here, we review the development and applications of
chemical reporters for bacterial glycans, including peptidoglycan,
lipopolysaccharide, glycoproteins, teichoic acids, and capsular polysaccharides,
as well as mycobacterial glycans, including trehalose glycolipids
and arabinan-containing glycoconjugates. We cover in detail how bacteria-targeting
chemical reporters are designed, synthesized, and evaluated, how they
operate from a mechanistic standpoint, and how this information informs
their judicious and innovative application. We also provide a perspective
on the current state and future directions of the field, underscoring
the need for interdisciplinary teams to create novel tools and extend
existing tools to support fundamental and translational research on
bacterial glycans.